U.S. Commercial Services Stock News

Shareholders of Asana, Inc. ( NYSE:ASAN ) will be pleased this week, given that the stock price is up 14% to US$14.16...

With a price-to-earnings (or "P/E") ratio of 60.1x Somnigroup International Inc. ( NYSE:SGI ) may be sending very...

Centuri Holdings, Inc. ( NYSE:CTRI ) shares have had a really impressive month, gaining 28% after a shaky period...

Triumph Financial, Inc. saw its stock jump after a regulatory filing showed that institutional investor Creative Planning opened a new position, a move that is often interpreted as signaling fresh confidence in a bank's long term trajectory. See our latest analysis for Triumph Financial. The buying interest from Creative Planning comes as Triumph’s share price has rebounded in the short term, with an 11.85% 7 day share price return and 12.65% 30 day share price return. However, this sits...

If you are wondering whether Bank of New York Mellon is still good value after its big run, you are not alone. This is exactly what we are going to unpack. The stock has climbed 2.3% over the last week, 5.5% over the last month and is now up a striking 47.2% year to date, with 42.9% over 1 year, 178.6% over 3 years and 218.3% over 5 years. This naturally raises the question of how much upside might be left. Recent headlines have focused on how large custody banks like BNY Mellon are...

Those holding Dave & Buster's Entertainment, Inc. ( NASDAQ:PLAY ) shares would be relieved that the share price has...

W.W. Grainger (GWW) has been drifting lower this year after a very strong multi year run, leaving some long term holders wondering whether the recent pullback is a reset or an opportunity. See our latest analysis for W.W. Grainger. At around $968.91 per share, the recent slide has pulled W.W. Grainger’s year to date share price return into negative territory. Its five year total shareholder return still reflects a very strong long term compounding story, which suggests momentum has cooled...

Wondering whether Simon Property Group is still worth buying after its big multi year run, or if most of the easy gains are already behind it? You are not alone, and that is exactly what we will unpack here. The stock now trades around $183.32, up a hefty 165.3% over five years and 81.8% over three years, even though shorter term returns have cooled, with the share price roughly flat over 30 days and up about 5.8% over the past year. Recent headlines have focused on Simon doubling down on...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Urban Outfitters (URBN) just reported a record third quarter, beating expectations on both earnings and revenue as every brand and region posted positive comparable sales, giving investors fresh reason to revisit the stock. See our latest analysis for Urban Outfitters. The stock has had a choppy reaction to the news, with the share price slipping 4.38% over the last day to $75.72. However, a 30 day share price return of 17.41% and a standout 1 year total shareholder return of 51.5% suggest...

Molina Healthcare has recently become the subject of multiple securities class action lawsuits and shareholder investigations alleging failures to disclose material adverse information about its medical cost trend assumptions, premium rate misalignment, and 2025 financial guidance cuts. These legal actions highlight concerns not just about current earnings pressure, but also about governance, disclosure practices, and how reliably investors can assess Molina’s underlying medical cost...

If you are wondering whether Hims & Hers Health is still a smart buy after its huge run, or if the easy money has already been made, this breakdown will help you decide whether the current price still stacks up against the fundamentals. The stock has cooled off a bit in the last month, down 6.5%, but that follows a powerful 58.8% gain year to date and a massive 452.0% jump over 3 years that has completely changed how the market views the business. Recent headlines have focused on Hims & Hers...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

We note that the Atlas Lithium Corporation ( NASDAQ:ATLX ) Independent Director, Robert Roger Noriega, recently sold...

In early December 2025, Charles River Laboratories International, Inc. shared an upbeat business update at the Evercore 8th Annual Healthcare Conference in Coral Gables, highlighting ongoing improvements in its Discovery and Safety Assessment net book-to-bill ratio since the third quarter. This steady month-by-month strengthening in orders since mid-2025 offers investors a clearer read-through on underlying demand recovery in one of the company’s core segments. With management pointing to...

In recent weeks, Nu Holdings has seen positive earnings estimate revisions, an analyst upgrade to Outperform from Grupo Santander, and confirmation that its planned 2026 Brazilian banking license should not alter day‑to‑day operations or capital requirements. Together, these developments point to growing confidence in Nu’s core Latin American franchise and its ability to integrate tighter regulation without disrupting customers. We’ll now examine how this renewed analyst optimism around Nu’s...

Prologis (PLD) has quietly outpaced many peers this year, and that climb is starting to make investors ask a simple question: is the current price still reasonable given its fundamentals? See our latest analysis for Prologis. The recent pullback, with a 1 day share price return of negative 0.78 percent from 128.18 dollars, comes after a strong 90 day share price return of 12.78 percent and a solid 5 year total shareholder return of 51.44 percent. This suggests momentum is still broadly intact...

Most readers would already be aware that Lincoln Educational Services' (NASDAQ:LINC) stock increased significantly by...

PNC Financial Services Group (PNC) has quietly outperformed many big-bank peers over the past month, and that steady climb is getting investors to revisit where this regional heavyweight might be headed next. See our latest analysis for PNC Financial Services Group. That recent 8.37% 1 month share price return has helped PNC claw back from a softer quarter, and with a 5 year total shareholder return of 64.94 percent, the stock still looks like a steady compounder rather than a short term...

In early December 2025, American Bitcoin Corp., a Trump-linked Bitcoin miner, faced intense volatility after a lock-up expiration allowed early pre-merger investors to sell previously restricted shares, triggering heavy trading, multiple halts, and profit-taking amid a weak backdrop for crypto-related equities. Despite the turbulence and heightened scrutiny over its China-made mining rigs, company leaders emphasized their long-term commitment, continued Bitcoin accumulation, and a recent...

UroGen Pharma Ltd. ( NASDAQ:URGN ) shareholders have had their patience rewarded with a 26% share price jump in the...

Cigna Group (CI) has been drifting lower recently. That kind of slow slide often makes investors wonder if the market is overlooking a fundamentally solid healthcare business with consistent cash generation. See our latest analysis for Cigna Group. Over the past year, Cigna Group’s share price returns have been choppy, with a recent 7 day share price return of minus 3.57 percent and a 90 day share price return of minus 12.08 percent. However, the 5 year total shareholder return of 37.98...

Wondering if Capricor Therapeutics is still a smart buy after its huge run, or if you are late to the party? This breakdown will help you decide whether the current price actually makes sense. The stock has exploded recently, jumping about 375% over the last week and 308.4% over the past month, and is now sitting around $25.40 after years of strong gains. That kind of move has come alongside renewed investor focus on Capricor’s cell and exosome based therapies, including its work in rare...

Wondering if Intel at around $40.50 is still a bargain or if most of the upside has already been priced in? You are not the only one trying to figure out whether now is the moment to buy or wait. Over the last week Intel is up about 10.0%, adding to a 9.4% gain over the past month and a striking 100.3% return year to date. This has quickly changed how investors are thinking about both its upside and its risks. Much of this move has been driven by renewed optimism around Intel's foundry...